FDA Approves Xacduro for Difficult-to-Treat Bacterial Pneumonia

TUESDAY, May 30, 2023 -- The U.S. Food and Drug Administration has approved Xacduro (sulbactam for injection; durlobactam for injection) as a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia...